Turning our Trials into Discovery Instruments: Closing the Innovation Loop with Multiscalar Data Integration from Research Kidney Biopsy Trials

• Integrating transcriptomic, genomic, proteomic and metabolomic datasets to define disease mechanisms
• Validating associations strongly enough to overcome investor and development scepticism
• Translating molecular phenotypes into targets with realistic therapeutic potential

Speakers:

Matthias Kretzler

Professor of Medicine

University of Michigan